Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review
WS Choi, YS Woo, SM Wang, HK Lim, WM Bahk - PloS one, 2022 - journals.plos.org
Comorbid psychiatric disorders in adults with ADHD are important because these
comorbidities might complicate the diagnosis of ADHD and also worsen the prognosis …
comorbidities might complicate the diagnosis of ADHD and also worsen the prognosis …
ADHD: Current concepts and treatments in children and adolescents
Attention deficit hyperactivity disorder (ADHD) is among the most frequent disorders within
child and adolescent psychiatry, with a prevalence of over 5%. Nosological systems, such as …
child and adolescent psychiatry, with a prevalence of over 5%. Nosological systems, such as …
Autism in England: assessing underdiagnosis in a population-based cohort study of prospectively collected primary care data
Background Autism has long been viewed as a paediatric condition, meaning that many
autistic adults missed out on a diagnosis as children when autism was little known. We …
autistic adults missed out on a diagnosis as children when autism was little known. We …
Attention-deficit/hyperactivity disorder medications and long-term risk of cardiovascular diseases
Importance Use of attention-deficit/hyperactivity disorder (ADHD) medications has increased
substantially over the past decades. However, the potential risk of cardiovascular disease …
substantially over the past decades. However, the potential risk of cardiovascular disease …
Overdiagnosis of attention-deficit/hyperactivity disorder in children and adolescents: a systematic sco** review
Importance Reported increases in attention-deficit/hyperactivity disorder (ADHD) diagnoses
are accompanied by growing debate about the underlying factors. Although overdiagnosis is …
are accompanied by growing debate about the underlying factors. Although overdiagnosis is …
Pharmacologic treatment of attention deficit–hyperactivity disorder
S Cortese - New England Journal of Medicine, 2020 - Mass Medical Soc
Pharmacologic Treatment of ADHD Amphetamines and methylphenidate and, less often,
nonstimulants (atomoxetine, clonidine, and guanfacine) are used to treat ADHD …
nonstimulants (atomoxetine, clonidine, and guanfacine) are used to treat ADHD …
Psychotropic medicine consumption in 65 countries and regions, 2008–19: a longitudinal study
R Brauer, B Alfageh, JE Blais, EW Chan… - The Lancet …, 2021 - thelancet.com
Summary Background The WHO Comprehensive Mental Health Action Plan 2013–2030
encourages routine collection and reporting of a set of essential mental health indicators …
encourages routine collection and reporting of a set of essential mental health indicators …
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic …
Background Methylphenidate is the most frequently prescribed medication for the treatment
of ADHD in children and adolescents in many countries. Although many randomised …
of ADHD in children and adolescents in many countries. Although many randomised …
Risk of cardiovascular diseases associated with medications used in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis
Importance Use of attention-deficit/hyperactivity disorder (ADHD) medications has increased
substantially over the past decades, but there are concerns regarding their cardiovascular …
substantially over the past decades, but there are concerns regarding their cardiovascular …
Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults
S Weibel, O Menard, A Ionita, M Boumendjel… - L'encephale, 2020 - Elsevier
Attention deficit with or without hyperactivity disorder (ADHD) is one of the most frequent
neuropsychiatric disorders, and affects 2–4% of adults. In contrast with many European …
neuropsychiatric disorders, and affects 2–4% of adults. In contrast with many European …